Literature DB >> 3308376

Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.

G Marchesini1, G P Bianchi, G Forlani, A G Rusticali, D Patrono, M Capelli, M Zoli, P Vannini, E Pisi.   

Abstract

To clarify the pathogenesis of impaired glucose tolerance in patients with cirrhosis, several factors possibly affecting carbohydrate metabolism were studied in 12 cirrhotic patients with different blood glucose responses to an oral glucose tolerance test. Glucose levels, 120 min after the load, were inversely and significantly related to insulin sensitivity, measured by means of the euglycemic "glucose clamp" technique (r = -0.746). Basal and glucose-induced insulin secretion (insulin and C-peptide levels) only slightly correlated with glucose tolerance, which was not related to functional liver cell mass (galactose elimination), portal-systemic shunting (degree of varices at endoscopy), or maximal glucose-independent insulin secretion (peak C-peptide levels after a glucagon test). Multiple regression analysis identified insulin sensitivity and liver cell mass as the independent variables able to explain most of the variance of 120-min blood glucose (about 84%), and both of them contributed considerably to the regression. While reduced insulin sensitivity is probably the main cause of impaired glucose tolerance, the reduced hepatocellular mass only appears to modulate the degree, and therefore the clinical relevance, of this defect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308376     DOI: 10.1007/BF01300198

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  On the Theory of Scales of Measurement.

Authors:  S S Stevens
Journal:  Science       Date:  1946-06-07       Impact factor: 47.728

2.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

3.  Glucose intolerance and insulin resistance in patients with liver disease.

Authors:  J R Collins; O B Crofford
Journal:  Arch Intern Med       Date:  1969-08

4.  The euglycemic clamp technique in patients with liver cirrhosis.

Authors:  P Vannini; G Forlani; G Marchesini; A Ciavarella; M Zoli; E Pisi
Journal:  Horm Metab Res       Date:  1984-07       Impact factor: 2.936

5.  Determination of the hepatic elimination capacity (Lm) of galactose by single injection.

Authors:  N Tygstrup
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

6.  Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.

Authors:  Y Iwasaki; H Sato; A Ohkubo; T Sanjo; S Futagawa; M Sugiura; S Tsuji
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

7.  Degradation and secretion of insulin in hepatic cirrhosis.

Authors:  Y Iwasaki; A Ohkubo; H Kajinuma; Y Akanuma; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

8.  Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes.

Authors:  A V Greco; A Bertoli; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi
Journal:  Horm Metab Res       Date:  1980-11       Impact factor: 2.936

9.  Insulin resistance and insulin receptors in hepatic cirrhosis.

Authors:  A T Blei; D C Robbins; E Drobny; G Baumann; A H Rubenstein
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  4 in total

Review 1.  Changes in nutritional status after liver transplantation.

Authors:  Michela Giusto; Barbara Lattanzi; Vincenza Di Gregorio; Valerio Giannelli; Cristina Lucidi; Manuela Merli
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.

Authors:  N Tanabe; M Ishii; Y Sato; T Akahane; N Kobayashi; H Gama; T Iwasaki; T Toyota
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Authors:  Tsuyoshi Ishikawa; Shogo Shiratsuki; Takashi Matsuda; Takuya Iwamoto; Taro Takami; Koichi Uchida; Shuji Terai; Takahiro Yamasaki; Isao Sakaida
Journal:  J Gastroenterol       Date:  2013-10-05       Impact factor: 7.527

4.  Insulin sensitivity and variability in hepatitis C virus infection using direct measurement.

Authors:  Nizar A Mukhtar; Peter Bacchetti; Claudia E Ayala; Jennifer Melgar; Spencer Christensen; Jacquelyn J Maher; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.